ESC Premium Access

Knockout of purinergic receptor Y13 (P2Y13) results in an improved outcome in metabolic syndrome in mice

Topic: Lipid Metabolism, Metabolic Syndrome, Diabetes

Congress Session

About the speaker

Mr Julian Merz

University of Freiburg, Freiburg (Germany)
0 follower

5 more presentations in this session

A novel senolytic drug, seno-7284 ameliorates age-related cardiometabolic diseases

Speaker: Doctor G. Katsuumi (Niigata, JP)

Thumbnail

Maternal high-fat diet exaggerates the development of diet-induced insulin resistance in adult offspring by enhancing pyroptosis through augmented gasdermin D-mediated pore formation

Speaker: Doctor N. Wada (Kyoto, JP)

Thumbnail

A distinct LDL profile to predict the risk of cardiovascular disease in familial hypercholesterolemia subjects: initial pre-clinical results

Speaker: Miss A. Hoogendoorn (Adelaide, AU)

Thumbnail

Endothelial mitochondrial fragmentation contributes to vascular dysfunction in hypertension

Speaker: Associate Professor X. Zhang (Xi'an, CN)

Thumbnail

Endothelial autophagy triggers nuclear enrichment of miR-126-5p via a Mex3a-dependent pathway to confers endothelial protection and prevent atherosclerosis.

Speaker: Doctor D. Santovito (Munich, DE)

Thumbnail

Access the full session

Metabolic interfaces in vascular disease

Speakers: Mr J. Merz, Doctor G. Katsuumi, Doctor N. Wada, Miss A. Hoogendoorn, Associate Professor X. Zhang...
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk